Insider · CIK 0001724870

Sandercock Colin

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001724870

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-09	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+200K sh	—	—	200,000
2025-12-03	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+70K sh	—	—	70,000
2025-09-26	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+30K sh	—	—	30,000
2025-03-21	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+200K sh	—	—	200,000
2024-06-05	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+60K sh	—	—	60,000
2024-03-06	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+175K sh	—	—	175,000
2023-07-21	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+75K sh	—	—	75,000
2023-02-16	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+100K sh	—	—	100,000
2022-03-25	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+16.7K sh	—	—	16,667
2022-02-09	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+60K sh	—	—	60,000
2021-02-10	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+50K sh	—	—	50,000
2020-08-05	CUECue Biopharma, Inc.M Exercise/Conversion	SVP, GENERAL COUNSEL	MExercise/Conversion	+13.4K sh	$7.50	+$100K	30,499
2020-08-05	CUECue Biopharma, Inc.S Sale	SVP, GENERAL COUNSEL	SSale	−13.4K sh	$20.00	−$267K	17,125
2020-08-05	CUECue Biopharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, GENERAL COUNSEL	MExercise/Conversion	−13.4K sh	—	—	130,000
2020-08-05	CUECue Biopharma, Inc.M Exercise/Conversion	SVP, GENERAL COUNSEL	MExercise/Conversion	+13.3K sh	$7.50	+$99.6K	30,399
2020-08-05	CUECue Biopharma, Inc.S Sale	SVP, GENERAL COUNSEL	SSale	−13.3K sh	$20.00	−$265K	17,125
2020-08-05	CUECue Biopharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, GENERAL COUNSEL	MExercise/Conversion	−13.3K sh	—	—	130,100
2020-08-04	CUECue Biopharma, Inc.M Exercise/Conversion	SVP, GENERAL COUNSEL	MExercise/Conversion	+201 sh	$7.50	+$1,507.5	17,326
2020-08-04	CUECue Biopharma, Inc.S Sale	SVP, GENERAL COUNSEL	SSale	−201 sh	$20.05	−$4,030.05	17,125
2020-08-04	CUECue Biopharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, GENERAL COUNSEL	MExercise/Conversion	−201 sh	—	—	143,374
2020-08-03	CUECue Biopharma, Inc.M Exercise/Conversion	SVP, GENERAL COUNSEL	MExercise/Conversion	+6,425 sh	$7.50	+$48.2K	23,550
2020-08-03	CUECue Biopharma, Inc.S Sale	SVP, GENERAL COUNSEL	SSale	−6,425 sh	$20.00	−$129K	17,125
2020-08-03	CUECue Biopharma, Inc. · Stock Option (right to buy)M Exercise/Conversion	SVP, GENERAL COUNSEL	MExercise/Conversion	−6,425 sh	—	—	143,575
2020-02-05	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+20K sh	—	—	20,000
2019-06-10	CUECue Biopharma, Inc.P Purchase	SVP, GENERAL COUNSEL	PPurchase	+15K sh	$7.90	+$119K	17,125
2019-06-10	CUECue Biopharma, Inc.P Purchase	SVP, GENERAL COUNSEL	PPurchase	+14.9K sh	$7.93	+$118K	16,938
2019-06-07	CUECue Biopharma, Inc.P Purchase	SVP, GENERAL COUNSEL	PPurchase	+100 sh	$7.35	+$735	2,100
2019-06-06	CUECue Biopharma, Inc.P Purchase	SVP, GENERAL COUNSEL	PPurchase	+2,000 sh	$7.10	+$14.2K	2,000
2019-03-06	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+50K sh	—	—	50,000
2019-03-06	CUECue Biopharma, Inc. · Stock Option (right to buy)A Award	SVP, GENERAL COUNSEL	AAward	+100K sh	—	—	100,000
2017-12-27	CUECue Biopharma, Inc. · Stock OptionsA Award	SVP, GENERAL COUNSEL	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Apr 104
Sandercock Colin0001193125-26-151202
SEC(opens sec.gov)
Dec 54
Sandercock Colin0001193125-25-310067
SEC(opens sec.gov)
Mar 254
Sandercock Colin0000950170-25-044345
SEC(opens sec.gov)
Jun 74
Sandercock Colin0000950170-24-070562
SEC(opens sec.gov)
Mar 84
Sandercock Colin0000950170-24-028613
SEC(opens sec.gov)
Jul 254
Sandercock Colin0001209191-23-043274
SEC(opens sec.gov)
Feb 214
Sandercock Colin0001209191-23-011249
SEC(opens sec.gov)
Mar 294
Sandercock Colin0001209191-22-021456
SEC(opens sec.gov)
Feb 124
Sandercock Colin0000899243-21-006355
SEC(opens sec.gov)
Aug 104/A
Sandercock Colin0001209191-20-045921
SEC(opens sec.gov)
Aug 74
Sandercock Colin0001209191-20-045702
SEC(opens sec.gov)
Aug 54
Sandercock Colin0001209191-20-045144
SEC(opens sec.gov)

Companies

Cue Biopharma, Inc.SVP, GENERAL COUNSELCUE

Address

C/O CUE BIOPHARMA, INC. 40 GUEST STREET

BOSTON, MA, 02135